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Abstract
Aims/hypothesis The aim of the study was to examine the
course (incidence, recurrence/persistence) of depressive
symptoms in primary care patients with type 2 diabetes
a n dt oi d e n t i f ys i g n i f i c a n tp r edictors of these different
course patterns.
Methods A cohort of 2,460 primary care patients with
type 2 diabetes was assessed for demographic, clinical and
psychological factors in 2005 and followed-up in 2007 and
2008. Depression was defined as a score of ≥12 on the
Edinburgh Depression Scale. Multivariate logistic regres-
sion analyses were used to determine whether several
depression-course patterns could be predicted by means of
demographics, medical co-morbidities and psychological
factors.
Results A total of 630 patients (26%) met the criterion for
depression at one or more assessments. In the subgroup with
no baseline depression, incident depression at follow-up was
present in 14% (n0310), while recurrence/persistence in
those with baseline depression was found in 66% (n0212).
The presence of any depression was associated with being
female, low education, non-cardiovascular chronic diseases,
stressful life events and a self-reported history of depression.
Incident depression was predicted by female sex, low edu-
cation and depression history, while patients with a history
of depression had a 2.5-fold increased odds of recurrent/
persistent depression.
Conclusions/interpretation Depression is common in pri-
mary care patients with type 2 diabetes, with one in seven
patientsreportingincidentdepressionduringa2.5yearperiod.
Once present, depression often becomes a chronic/recurrent
condition in this group. In order to identify patients who are
vulnerable todepression, clinicianscan use questionnaire data
and/or information about the history of depression.
Keywords Course.Depression.Incidence.Persistence.
Prevalence.Recurrence.Type2diabetes
Abbreviations
COPD Chronic obstructive pulmonary disease
DiaDDZoB Diabetes, Depression, Type D Personality
Zuidoost-Brabant
EDS Edinburgh Depression Scale
M0 Baseline assessment in 2005
M1 Follow-up assessment in 2007
M2 Follow-up assessment in 2008
Introduction
Compared with controls without diabetes, the risk of depres-
sion is nearly doubled in individuals with type 2 diabetes,
affecting approximately one in every five patients [1]. A
recent meta-analysis has shown that individuals with previ-
ously diagnosed diabetes have an increased risk of depres-
sion relative to those with impaired glucose metabolism or
undiagnosed diabetes [2]. Co-morbid depression not only
has a profound negative impact on patients’ quality of life
[3], but is also related to worse glycaemic control [4], the
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[5, 6] and a higher mortality risk [7]. Despite the growing
bodyofliterature demonstrating the harmful effects ofdepres-
sion in this patient group, the course of depression in type 2
diabetes has received relatively little research attention.
Previous cross-sectional research has mainly focused on
prevalence estimates of depression, finding particularly high
rates in women, patients treated in specialist settings and
those with co-morbid medical conditions [1, 8–11]. Further-
more, the longitudinal studies that have been conducted
have mainly focused on incident depression in type 2 dia-
betes. A recent meta-analysis of 11 studies concluded that
people with type 2 diabetes have a 24% increased odds of
incident depression compared with people without diabetes
[12]. However, as only one of the studies excluded people
with a history of depression in the years before study onset,
the results of this study are likely to overestimate the risk for
incident depression in the strictest sense (i.e. first occur-
rence) [12]. Although a few studies have examined the
course of depression once symptoms were present (recur-
rence/persistence, remission), most had considerable limita-
tions: for example, a small sample size (n<175) [13–15],
recruitment from specialist settings [15] or only two assess-
ments of depression [15, 16]. Two studies did not provide
strictly observational findings as they assessed depression in
the framework of an intervention study [13, 14]. One obser-
vational study of 506 patients with type 2 diabetes assessed
depression three times over a period of 18 months (with
9 month intervals) [17]. However, the authors combined
persistence estimates into the categories ‘condition at only
a single wave’, ‘condition at any two waves’ and ‘condition
at all three waves’, thereby impeding an evaluation of specific
course patterns.
To our knowledge, a large study simultaneously address-
ing different aspects of the course of depression in primary
care patients with type 2 diabetes is currently lacking.
Therefore, the main aim of the present study was to examine
severalcoursetrajectoriesofdepressivesymptoms(incidence,
recurrence/persistence) using data from three separate assess-
ments during a 2.5 year period and to gain insight in the
demographic, medical and psychological risk factors predict-
ing these different course patterns.
Methods
Methods and responserates oftheDiabetes, Depression, Type
D [‘distressed’] Personality Zuidoost-Brabant (DiaDDZoB)
Study have been described in detail elsewhere [18]. In short,
2,460 patients with type 2 diabetes (82% of those considered
for study inclusion)treated within77primary carepracticesin
South-East Brabant, the Netherlands, were recruited at the
baseline assessment in the second half of 2005 (M0). Of these
patients, nearly all (2,448) attended a baseline nurse-led
interview, while 75% (1,850) returned the self-report ques-
tionnaire that had to be completed at home. This cohort was
re-contactedforfollow-upassessmentsin2007(M1)and2008
(M2), and included 2,225 and 2,032 participants, respectively.
The study protocol of the DiaDDZoB Study was approved by
the medical research ethics committee of a local hospital, the
Máxima Medical Centre in Veldhoven (NL27239.015.09).
Written informed consent was obtained from all participants.
Assessment of depression Symptoms of depression during
the last 7 days were assessed using a validated Dutch ver-
sion of the Edinburgh Depression Scale (EDS) [19]. The
EDS was originally designed to assess postpartum depres-
sion [20], but has now been validated in non-postnatal
women [21], women around menopausal age [22], men
[23], community samples [24] and primary care patients
with type 2 diabetes [25]. The EDS is a ten-item self-
report questionnaire, in which each item is scored on a
four-point scale. Total EDS scores are determined by sum-
ming the scores of all ten individual items (total score range
0–30), with higher scores indicating higher levels of depres-
sive symptoms. A total score of 12 or more is commonly
used to identify patients with depression [24]. Using this
cut-off, we calculated dichotomised depression scores (no
depression/depression) for all three measurements. Patients
were considered to suffer from ‘any depression’ if they
obtained an EDS score ≥12 during at least one of the three
measurement occasions. To specify the course trajectory of
these depressive symptoms, we split the total sample into
two groups based on the baseline (M0) EDS score. ‘Incident
depression’ was determined in the subgroup with an EDS
score <12 at M0 (no baseline depression). Patients in this
group who obtained an EDS score ≥12 at M1 and/or M2
were considered incident cases. Rates of ‘recurrence/persis-
tence’ were examined in the remaining group of participants
who had an EDS score ≥12 at M0 (baseline depression).
Depression was labelled ‘recurrent/persistent’ if patients had
at least one other high EDS score at M1 or M2.
Baseline demographic, medical and psychological
predictors Baseline demographic data included sex, age,
marital status (having a partner vs being single) and educa-
tional level (middle/high vs low), and were acquired during
a patient interview led by the primary care practice nurse
and also by means of a self-report questionnaire. The pri-
mary care practice nurse took a medical history, after which
all self-reported medical diagnoses were verified through
inspection of the medical record. Indicators of microvascu-
lar disease were derived from standard-care laboratory tests
and physical examinations carried out by the Diagnostic
Centre Eindhoven, a primary care diagnostic institute. The
results from patients’ yearly digital fundus photography
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min level in a random urine sample was used as a proxy of
nephropathy[26].Macro-andmicroalbuminuriaweredefined
as urine albumin concentrations >200 and 20–200 mg/l,
respectively. All medical co-morbidities were combined into
three composite disease measures, i.e. cardiovascular diseases
(myocardial infarction, bypass/angioplasty, stroke and/or
arterial disease), microvascular complications (retinopathy
and/or micro-/macroalbuminuria) and other chronic condi-
tions (kidney disease, asthma/chronic obstructive pulmonary
disease[COPD],cancer,arthrosisand/orrheumatoidarthritis).
In addition, patients were asked if they had ever suffered from
depression. Non-diabetes-related stressful life events in
the previous 12 months (e.g. loss of a loved one, burglary,
relationship problems) were assessed by means of a single
questionnaire item.
Other patient characteristics The interview included one
question regarding ethnicity (white vs non-white). Baseline
treatment for diabetes and diabetes duration were docu-
mented by the primary care practice nurse. Standard-care
determinations of HbA1c concentrations and BMI were
provided by the Diagnostic Centre Eindhoven.
Statistical analyses Baseline sample characteristics and de-
scriptive statistics for the EDS data at all three measurement
occasions were calculated. To compare differences between
men and women, χ
2 tests were used for categorical data and
independent samples t tests for continuous data. Of all
demographic, clinical and psychological data needed for
the analyses, 27% was missing. As complete case analysis
would restrict the sample to 511 patients (21%), multivariate
imputation by chained equations was applied to impute
missing values (Electronic supplementary material [ESM]
Table 1), using the package MICE V2.0 [27] and the soft-
ware program R [28]. Adequate results can generally be
obtained by creating five to ten imputed datasets, retaining
final imputations per dataset after ten iterations [27, 29]. For
the present study, 20 imputed datasets were generated,
allowing ten iterations per set.
Following imputation, depression prevalence rates and
estimates for any, incident and recurrent/persistent depression
were calculated, pooling the results over the 20 individual
datasets. Multivariate logistic regression analyses were used
to determine whether these different depression course trajec-
tories could be predicted by means of: (1) demographics
(female sex, age, low education, being single); (2) medical
co-morbidities (prior cardiovascular disease, the presence of
microvascularcomplications,otherco-morbidconditions);(3)
stressful life events; and (4) self-reported history of depres-
sion. As missing EDS baseline data were also imputed, the
number of individuals classified in either the ‘incident depres-
sion’ or ‘recurrent/persistent depression’ subgroup varied
slightly per individual imputed dataset. Therefore, in addition
to reporting the pooled results of the regression analyses for
incident and recurrent/persistent depression, the range of n
across all 20 individual imputed datasets was provided. With
the exception of the multiple imputation procedure, all analy-
ses were performed using PASW Statistics version 17.0 (IBM
SPSS Statistics, Somers, NY, USA). A p value <0.05 was
considered to be statistically significant.
Results
Baseline sample characteristics Table 1 presents the char-
acteristics of the total DiaDDZoB sample before multiple
imputation (n02,460, 49% men, mean age 67 years) and the
number of missing values per variable. Overall, participants
were in relatively good glycaemic control (mean HbA1c
6.7% [50 mmol/mol]), and the majority were being treated
with a combination of diet and oral glucose-lowering agents.
Co-morbid diseases were common, with vascular disease
and other major (chronic) medical conditions being present
in one-third and one-half of all patients, respectively. Ad-
vanced microvascular complications, including retinopathy
and macroalbuminuria, were relatively rare. However, al-
most one in four patients had microalbuminuria. When
examining results separately for men and women, women
were shown to be significantly older, more commonly had a
low educational level and were more likely to be single.
Myocardial infarction, bypass/angioplasty procedures and
albuminuria were more prevalent in men, while the medical
history of women included more diagnoses of cancer, arthro-
sis and rheumatoid arthritis. Furthermore, women were more
likelytoreportahistoryofdepressionandatleastonestressful
life event in the past year.
Prevalence of depression Figure 1 shows the number of
patients with depression (EDS score ≥12) at the baseline
assessment in 2005 (M0) and the two follow-up occasions
(M1 and M2), after multiple imputation. Depression slowly
increased from 13% (M0)t o1 4 %( M 1)t o1 6 %( M 2). This
pattern was evident for both men and women after split-
ting by sex. Compared with men, the prevalence of depres-
sion was twice as high for women at each assessment.
Any depression, incidence and recurrence/persistence After
multiple imputation, 26% of the total sample (n0630)
reported an EDS score ≥12 at M0,M 1 and/or M2 (‘any
depression’). The presence of any depression was signifi-
cantly more likely in women compared with men (32%, n0
412 vs 18%, n0218; p<0.001). In the subgroup of patients
with an M0 EDS score <12 (no depression; n02,140),
incident depression at M1 or M2 was present in 310 indi-
viduals (14%), with a higher rate for women (18%, n0193
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Characteristic All (n02,460) n missing Men (n01,192) Women (n01,268) p value
Demographics
Age (years) 67±11 5 66±11 68±11 <0.001
Non-white 3 (78/2,424) 36 3 (36/1,174) 3 (42/1,250) 0.68
Low education level 64 (1,140/1,770) 690 53 (459/866) 75 (681/904) <0.001
Being single 25 (455/1,831) 629 16 (144/893) 33 (311/938) <0.001
Medical history
Cardiovascular disease 36 (842/2,368) 92 40 (458/1,157) 32 (384/1,211) <0.001
Myocardial infarction 12 (280/2,353) 107 16 (188/1,149) 8 (92/1,204) <0.001
Bypass/angioplasty 13 (312/2,358) 102 18 (207/1,153) 9 (105/1,205) <0.001
Stroke 7 (164/2,360) 100 8 (88/1,154) 6 (76/1,206) 0.21
Arterial disease 24 (559/2,349) 111 25 (287/1,142) 23 (272/1,207) 0.14
Microvascular disease 35 (612/1,769) 691 38 (334/886) 32 (278/883) 0.006
Retinopathy 5 (86/1,767) 693 4 (37/878) 6 (49/889) 0.21
Microalbuminuria
a 23 (477/2,077) 383 26 (264/1,003) 20 (213/1,074)
Macroalbuminuria
b 4 (72/2,077) 5 (46/1,003) 2 (26/1,074) <0.001
Other chronic conditions 50 (1,184/2,377) 83 44 (510/1,157) 55 (674/1,220) <0.001
Kidney disease 4 (95/2,339) 121 4 (47/1,144) 4 (48/1,195) 0.91
Asthma/COPD 13 (315/2,360) 100 13 (153/1,147) 13 (162/1,213) 0.99
Cancer 9 (222/2,351) 109 8 (90/1,144) 11 (132/1,207) 0.01
Arthrosis 34 (793/2,365) 95 27 (309/1,152) 40 (484/1,213) <0.001
Rheumatoid arthritis 7 (161/2,352) 108 4 (44/1,146) 10 (117/1,206) <0.001
Clinical values
Hyperglycaemia treatment 38
No treatment 1 (19/2,422) 1 (9/1,179) 1 (10/1,243)
Diet only 18 (432/2,422) 19 (219/1,179) 17 (213/1,243)
Diet, oral agents 75 (1,821/2,422) 76 (892/1,179) 75 (929/1,243)
Diet, oral agents, insulin 5 (114/2,422) 4 (46/1,179) 6 (68/1,243)
Diet, insulin 1 (33/2,422) 1 (10/1,179) 2 (23/1,243)
Other 0 (3/2,422) 0 (3/1,179) 0 (0/1,243) 0.04
Diabetes duration ≥3 years 61 (1,467/2,424) 36 59 (697/1,175) 62 (770/1,249) 0.24
HbA1c,% (mmol/mol) 6.7±0.9 (50±10) 61 6.7±0.8 (50±9) 6.7±0.9 (50±10) 0.28
BMI (kg/m
2) 29±5 234 28±4 30±5 <0.001
Psychosocial factors
History of depression 11 (248/2,345) 115 9 (97/1,146) 13 (151/1,199) 0.001
Stressful life event(s) 35 (635/1,800) 660 32 (280/881) 39 (355/919) 0.002
M0 depressive symptoms
EDS total score 6±5 715 5±4 7±5 <0.001
EDS score ≥12 12 (216/1,745) 8 (70/861) 17 (146/884) <0.001
M1 depressive symptoms
EDS total score 6±5 918 5±4 7±5 <0.001
EDS score ≥12 14 (210/1,542) 9 (66/741) 18 (144/801) <0.001
M2 depressive symptoms
EDS total score 6±5 1,226 5±5 7±5 <0.001
EDS score ≥12 15 (188/1,234) 10 (60/580) 20 (128/654) <0.001
Values are means±SD or % (n/n)
aAlbumin concentration of 20–200 mg/l
bAlbumin concentration of >200 mg/l
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2 analysis showed
that participants who were not depressed at baseline but did
have a self-reported history of depression were significantly
more likely to experience incident depression during follow-
up than those without such a history (33%, n052 vs 13%, n0
257; p<0.001). Of the 320 patients with an EDS score of ≥12
at M0, 66% also met the criterion for depression at M1 and/or
M2andwerethereforeconsideredtoberecurrently/persistently
depressed. The rate of recurrence/persistence was similar for
female and male patients (69%, n0151 vs 60%, n061; p0
0.09), but was significantly higher in those with a self-reported
history of depression (79%, n079 vs 60%, n0133; p00.001).
When considering specific patterns of remission and relapse,
34%(n0109)ofallinitiallydepressedpatientsatM0recovered
andremained belowtheEDS score cut-off at M1 and M2,1 5 %
(n047) relapsed at M2 and 38% (n0123) were still depressed
at both follow-ups.
Baseline risk factors predicting any depression Table 2
shows the pooled effect estimates of a multivariate logistic
regression analysis predicting the presence of any depres-
sion (EDS score ≥12 at M0,M 1 and/or M2) by several
baseline characteristics. In the first step, female sex and
low education were the only significant demographic pre-
dictors. In the second step, having co-morbid chronic med-
ical conditions was positively associated with depression,
while the presence of cardiovascular disease and microvas-
cular complications also increased the odds of depression
but did not reach statistical significance (p00.27 and p0
0.09, respectively). In the third step, having experienced
stressful life events during the past year nearly doubled the
odds for depression, while in the final step participants with a
history of depression had an almost fivefold increased odds of
reporting depression during at least one assessment occasion.
In order to test whether sex was an effect modifier, the
same regression analysis (excluding sex in the first step) was
conducted for women (n01,268) and men (n01,192) sepa-
rately. After entry of all variables in the model, low educa-
tional level (fully adjusted OR 1.93, 95% CI 1.24, 3.01 in
women vs OR 1.56, 95% CI 1.02, 2.39 in men), stressful life
events (OR 1.90, 95% CI 1.40, 2.59 vs OR 1.83, 95% CI
1.25, 2.68) and a history of depression (OR 4.53, 95% CI
2.95, 6.95 vs OR 5.52, 95% CI 3.38, 9.01) were significantly
associated with depression for both sexes. In addition, the
non-cardiovascular chronic medical conditions played a sig-
nificant role in the model for women (OR 1.51, 95% CI 1.12,
2.03), while for men no other significant predictors were
found (ESM Table 2).
Additional analyses in the total sample examining de-
pression risk for each medical co-morbidity separately
revealed that after correction for demographics, arthrosis
(OR 1.57, 95% CI 1.26, 1.96) and rheumatoid arthritis
(OR 1.57, 95% CI 1.04, 2.39) were the only significant
predictors (ESM Table 3).
Baseline risk factors predicting incident and recurrent/
persistent depression A multivariate logistic regression
analysis identical to the model described in Table 2 was
conducted to predict incident depression (range of n over all
20 datasets, 2,131–2,156; ESM Table 4). In the last step,
female sex (OR 1.63, 95% CI 1.20, 2.21), low education
(OR 1.62, 95% CI 1.12, 2.36) and self-reported history of
depression (OR 3.27, 95% CI 2.05, 5.22) were all associated
with incident depression, while microvascular disease, other
chronic conditions and stressful life events increased the
odds of depression by 25–33%, but did not reach statistical
significance (p00.14, 0.18 and 0.14, respectively). Repeat-
ing the analysis (excluding entry of history of depression in
the last step) in the group of patients reporting no history of
depression and no M0 depression (range of n, 1,967–1,992)
yielded similar results (data not shown). After splitting by
sex, self-reported history of depression was associated with
a three- to four-fold increased odds of incident depression in
both men and women (Table 3). Low education increased
the odds, butwasnotsignificant(p00.09and0.06inmenand
women, respectively).
Self-reported history of depression was the only signifi-
cant predictor of recurrent/persistent depression (range of n,
304–329; OR 2.54, 95% CI 1.23, 5.23). Similar results were
found when examining results separately for men and women
(women: OR 2.69, 95% CI 1.06, 6.82; men:OR2.76, 95% CI
0.64, 11.88), but failed to reach statistical significance in men
(p00.18; ESM Tables 5 and 6).
Discussion
Depression (defined as a high level of depressive symp-
toms) appeared to be a common co-morbid health problem
in primary care patients with type 2 diabetes, with one in
four patients suffering from depression at least once during a
2.5 year period. New occurrences of depressive symptoms
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Fig. 1 Prevalence of depression (EDS score ≥12) at baseline (M0)a n d
the two follow-up assessments (M1,M 2) for the total sample (n=2,460)
and examined separately formen (n=1,192)andwomen(n=1,268). Bars
representtotalgroup(black),men(darkgrey)andwomen(lightgrey);the
number shown above each bar represents the number with depression in
that group. p<0.001 for men vs women for all three assessments
612 Diabetologia (2012) 55:608–616were frequently observed among those with no symptoms at
baseline (14%). Once present, depressive symptoms tended
to be recurrent/persistent over time in two-thirds of all cases.
The cross-sectional prevalence estimates of our study
(13–16%) were slightly lower than the figure reported in a
previous meta-analysis (18%) [1], but did slowly increase
over time. This may reflect cohort ageing and the ensuing
development of additional co-morbidities and accompa-
nying functional limitations. In line with the results of a
previous study [17], expanding the time frame from cross-
sectional analyses (point prevalence) to a total estimate
across successive assessments (‘any depression’) revealed
a higher prevalence rate in a 2.5 year period, suggesting that
prevalence estimates taken at one point in time underestimate
the true scope of the problem.
The onset of depression in diabetes has been examined
several times before, but most of these studies (including
ours) have defined incident depression as the presence of
depression at a distinct follow-up time point in those with-
out baseline depression, rathert h a na l s ot a k i n gi n c i d e n t
cases during the whole follow-up period into account [12].
This definition does not allow for a correction for variable
follow-up length across studies by calculating annual inci-
dence rates, as studies with longer follow-up periods are
likely to miss more incident cases and as a consequence
would substantially underestimate true yearly incidence
rates.
Our finding that depressive symptoms have a high rate of
recurrence and chronicity in diabetes patients is in line with
previous research showing that approximately half of all
patients experiencing depressive symptoms at baseline also
reported depression 1 to 5 years later [15, 16]. Furthermore,
over 40% of diabetes patients with elevated depressive
symptomsappeartodevelopmajordepression within2years
[30]. However, to our knowledge, only two previous studies
have examined the course of depressive symptoms over
more than two assessments. In one study, 20% of all partic-
ipants obtained scores ≥16 on the Center for Epidemiological
Studies—Depression questionnaire at least twice [17]. A sec-
ond study among 245 diabetes patients (65% with type 2
diabetes) measured depressive symptoms at the beginning
and end of a 1 week diabetes education program and at
6 month follow-up. While the authors concluded that only
13% of their total sample was persistently depressed (i.e.
exceeded the criterion for depression symptoms at all three
time points), recurrent depression (depressed at least once
during follow-up) was found in two-thirds of the patients
depressedbeforethestartoftheprogramme[14].Eventhough
this study included a psycho-educational intervention pro-
gram incorporating coping skills training, the results were
roughly comparable with those from our study.
With regard to prognostic factors, female sex, a low
educational level, non-cardiovascular chronic medical con-
ditions, stressful life events and a self-reported history of
depression were associated with the presence of any depres-
sion. Previous cross-sectional studies have shown an asso-
ciation between prevalent depression and the presence of
co-morbidchronicdiseasesindiabetespatients[8,9]andhave
suggested that a large number of general life stressors, in
addition to more diabetes-specific distress, can contribute to
Table 2 Multivariate logistic regression analysis predicting any depression (EDS score ≥12 at M0,M 1 and/or M2) by baseline demographic factors,
medical co-morbidities, stressful life events and self-reported history of depression (n02,460)
Variable Model 1 Model 2 Model 3 Model 4
Demographic factors
Female sex 1.86 (1.51, 2.29) 1.87 (1.51, 2.31) 1.82 (1.47, 2.25) 1.74 (1.39, 2.17)
Age 1.00 (0.99, 1.01) 0.99 (0.98, 1.00) 1.00 (0.99, 1.01) 1.00 (0.99, 1.01)
Low education level 1.66 (1.25, 2.22) 1.65 (1.24, 2.19) 1.66 (1.24, 2.23) 1.75 (1.28, 2.38)
Being single 1.28 (0.98, 1.68) 1.27 (0.97, 1.68) 1.19 (0.90, 1.57) 1.18 (0.88, 1.56)
Medical co-morbidities
Cardiovascular disease
a 1.13 (0.91, 1.40) 1.12 (0.90, 1.39) 1.10 (0.88, 1.38)
Microvascular disease
b 1.25 (0.97, 1.60) 1.24 (0.96, 1.60) 1.25 (0.96, 1.62)
Other chronic conditions
c 1.50 (1.19, 1.87) 1.44 (1.15, 1.82) 1.36 (1.07, 1.73)
Stressful life events 1.90 (1.51, 2.40) 1.86 (1.46, 2.38)
History of depression 4.90 (3.53, 6.82)
Values are OR (95% CI)
Model 1: demographic factors; Model 2: model 1+medical co-morbidities; Model 3: model 2+stressful life events; Model 4: model 3+history of
depression
aMyocardial infarction, bypass/angioplasty, stroke and/or arterial disease
bRetinopathy, micro-/macroalbuminuria
cKidney disease, asthma/COPD, cancer, arthrosis and/or rheumatoid arthritis
Diabetologia (2012) 55:608–616 613depressive symptoms [8]. However, the logistic regression
analysis predicting incident depression in the subgroup with
no baseline depression limited the results to female sex, low
education and history ofdepression, whilerecurrent/persistent
depression in those patients with baseline depression left only
depression history as a significant predictor in the model.
Twoprevious studies aiming toidentifybaseline predictors
of ‘persistent’ depressive symptoms reported conflicting
results. In one study, low level of education, the presence of
multiple complications and treatment without insulin signifi-
cantly predicted persistent depression [14], while the other
describedanimportantroleformorepsychologicallyorientated
factors, including baseline severity of depression, emotional
problems due to diabetes and the extent to which depression
disruptedthepatient’squalityoflife[15].Eventhoughvascular
complications are often cited as an important determinant of
disease burden in diabetes, macro- and microvascular
conditions were not associated with depression in any of the
present analyses. One possible explanation may lie in the fact
that our study focused on baseline and pre-baseline factors as
potential predictors of depression. However, the onset or pro-
gression of medical conditions and cardiovascular procedures
during follow-up are likely candidates to trigger new cases of
depressionor hamper recoveryfrom alreadyexistingemotional
problems. This hypothesis is partly supported by a study in
which coronary procedures during follow-up (but not incident
macro- and microvascular complications) were associated with
major depression at the 5 year follow-up [16]. Alternatively,
rather than examining the mere presence of any macro- or
microvascular conditions, it could be that having multiple
(vascular) co-morbidities (and probably accompanying func-
tional limitations) is what particularly increases the odds of
depression [8–10].
Self-reported history of depression was the only factor
that consistently identified those individuals who had in-
creased odds of experiencing any kind of depression during
a period of 2.5 years, even after controlling for demograph-
ics, medical co-morbidities and stressful life events. These
Table 3 Multivariate logistic regression analysis predicting incident depression by baseline demographic factors, medical co-morbidities, stressful
life events and self-reported history of depression, examined separately for men and women
Variable Model 1 Model 2 Model 3 Model 4
Men (range n01,081–1,096)
Demographic factors
Age 1.01 (0.99, 1.03) 1.00 (0.98, 1.02) 1.00 (0.98, 1.03) 1.00 (0.98, 1.03)
Low education level 1.56 (0.96, 2.54) 1.51 (0.92, 2.48) 1.54 (0.93, 2.54) 1.56 (0.94, 2.60)
Being single 1.11 (0.58, 2.14) 1.11 (0.57, 2.13) 1.08 (0.56, 2.07) 0.99 (0.50, 1.95)
Medical co-morbidities
Cardiovascular disease
a 1.42 (0.87, 2.31) 1.42 (0.87, 2.31) 1.43 (0.87, 2.34)
Microvascular disease
b 1.30 (0.79, 2.12) 1.30 (0.80, 2.14) 1.35 (0.82, 2.20)
Chronic conditions
c 1.28 (0.76, 2.15) 1.24 (0.74, 2.09) 1.20 (0.71, 2.04)
Stressful life events 1.40 (0.82, 2.39) 1.38 (0.81, 2.36)
History of depression 3.99 (1.98, 8.04)
Women (range n01,042–1,064)
Demographic factors
Age 1.01 (0.99, 1.03) 1.01 (0.98, 1.03) 1.01 (0.99, 1.03) 1.01 (0.99, 1.03)
Low education level 1.59 (0.95, 2.68) 1.59 (0.94, 2.68) 1.59 (0.94, 2.68) 1.69 (0.99, 2.88)
Being single 1.14 (0.75, 1.74) 1.12 (0.73, 1.72) 1.10 (0.71, 1.69) 1.11 (0.72, 1.70)
Medical co-morbidities
Cardiovascular disease
a 0.92 (0.61, 1.39) 0.92 (0.61, 1.38) 0.91 (0.60, 1.37)
Microvascular disease
b 1.35 (0.83, 2.19) 1.34 (0.82, 2.19) 1.34 (0.81, 2.20)
Chronic conditions
c 1.35 (0.94, 1.93) 1.34 (0.93, 1.92) 1.27 (0.88, 1.84)
Stressful life events 1.24 (0.83, 1.86) 1.24 (0.82, 1.88)
History of depression 2.93 (1.64, 5.26)
Values are OR (95% CI)
Model 1: demographic factors; Model 2: model 1+medical co-morbidities; Model 3: model 2+stressful life events; Model 4: model 3+history of
depression
aMyocardial infarction, bypass/angioplasty, stroke and/or arterial disease
bRetinopathy, micro-/macroalbuminuria
cKidney disease, asthma/COPD, cancer, arthrosis and/or rheumatoid arthritis
614 Diabetologia (2012) 55:608–616results are valuable for primary care, as they clearly show
that a simple self-report question is highly predictive of
future depression. Additional monitoring may be required
in patients who report a history of depression.
Some limitations of the present study need to be men-
tioned. First, depression was assessed by means of a self-
report questionnaire, while the gold standard for a diagnosis
of depression is a standardised psychiatric diagnostic inter-
view. Although 30–40% of patients with an increased level
of depressive symptoms are clinically depressed [11, 31],
self-reported depressive symptoms have been shown to
predict the development of major depression [30] and ad-
verse health outcomes [5] in diabetes patients. Second, a
more accurate measurement of incident depression can be
achieved in studies also covering the time period(s) between
separate measurement occasions, for example by using
handheld computers for the assessment of depression. In
case researchers do not want or are not able to use these
devices, other authors have argued that fluctuating course
types are best studied in designs with at least three measure-
ments [32]. Third, although we aimed to study the course of
depression in this cohort, no information was available on
either pharmacological or psychotherapeutic treatment of
depression during the study. However, this potential source
of bias is most likely restricted to a minority, as depression
often goes unrecognised and untreated in patients with dia-
betes [33]. Fourth, while interpreting our results, it has to be
borne in mind that 27% of all demographic, clinical and
psychological data needed for the analyses were missing
and imputed using multivariate imputation techniques.
However, several authors have argued that multiple imputation
is preferred over other missing data approaches, including
complete case analysis,in the case of complex incomplete data
problems [27, 29]. Finally, the vast majority of individuals in
oursample(97%) werewhite,whichmaynot berepresentative
of other diabetes populations. The strengths of the study in-
clude the large sample of primary care patients with type 2
diabetes, the prospective observational design with multiple
depression assessments and the policy to verify self-reported
medical diagnoses by inspection of medical records.
In sum, our results show that as many as one in four
primary care patients with type 2 diabetes are confronted
with depression during a 2.5 year period. Once present,
depression often becomes a chronic/recurrent condition in
this group. Monitoring of emotional well-being/depression
seems warranted and does not necessarily have to be very
elaborate, but should be embedded in collaborative care
approaches [34]. Moreover, given that a considerable number
of patients do not benefit from the current pharmacological
and psychotherapeutic treatment modalities, future research
efforts are required to further optimise depression outcomes
for depressed patients with type 2 diabetes [34]. Web-based
treatment of depression in diabetes appears to be effective and
c a nb ee m p l o y e dt oh e l pt ob a t t l et h i sc o m m o np r o b l e mi n
patients with diabetes with low costs [35].
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